GlassScriptPhysician profile
Stephen P Jones
NPI 1437128881
$17,633.55
in general payments reported to CMS, 2019-2025
10 companies · $563 in 2025
The $563 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14K · 2023: $3,032 · 2024: $205 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,750 · Food and Beverage: $1,024 · Education: $22.09 · Travel and Lodging: $4.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,750.00 |
| Food and Beverage | $1,023.57 |
| Education | $22.09 |
| Travel and Lodging | $4.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16,386.56 | 2022-2023 | |
| Digestive Care, INC. | $289.97 | 2025 | Pertzye |
| Mylan Specialty L.P. | $245.27 | 2023-2024 | Tobi Podhaler |
| Viatris Specialty LLC | $236.60 | 2025 | Tobi Podhaler |
| Chiesi USA, INC. | $136.32 | 2022 | |
| Genzyme Corporation | $135.36 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $124.48 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $36.75 | 2025 | |
| W. L. Gore & Associates, INC. | $27.07 | 2024 | Viatorr Endoprosthesis |
| Gilead Sciences, INC. | $15.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.